The Royal United Hospitals Bath NHS Foundation Trust runs the Royal United Hospital, a major acute-care hospital in Bath, England. The trust also runs the Royal National Hospital for Rheumatic Diseases and Sulis Hospital at Peasedown St John.

During the past decade, Royal United Hospital conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 20 clinical trials were completed, i.e. on average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 8 clinical trials were completed. i.e. 32% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal United Hospital" #1 sponsor was "University College, London" with 10 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 6 trials sponsored, "Pfizer" with 5 trials sponsored, "Abbott Diabetes Care" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 84 different institutions and companies that sponsored additional 71 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal United Hospital" #1 collaborator was "Cancer Research UK" with 9 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "National Health and Medical Research Council, Australia" with 3 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 3 trials as a collaborator and "Royal United Hospital Bath NHS Trust" with 3 trials as a collaborator. Other collaborators include 108 different institutions and companies that were collaborators in the rest 102 trials.

According to Clinical.Site data, the most researched conditions in "Royal United Hospital" are "Ovarian Cancer" (9 trials), "Lymphoma" (8 trials), "Fallopian Tube Cancer" (7 trials), "Multiple Myeloma" (7 trials) and "Atrial Fibrillation" (4 trials). Many other conditions were trialed in "Royal United Hospital" in a lesser frequency.

Most popular intervention types in "Royal United Hospital" are "Drug" (75 trials), "Other" (16 trials), "Biological" (14 trials), "Procedure" (12 trials) and "Device" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "cyclophosphamide" (6 trials), "carboplatin" (5 trials), "Paclitaxel" (4 trials) and "doxorubicin hydrochloride" (4 trials). Other intervention names were less common.

The vast majority of trials in "Royal United Hospital" are 90 trials for "All" genders, 21 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Royal United Hospital". 1 are not yet recruiting, 19 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Royal United Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Royal United Hospital, 2 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 12 trials that are defined as “Not Applicable".

Royal United Hospital has several departments that took part in Clinical trials: "Royal United Hospital; Oncology Department" - 6 trials, "Royal National Hospital for Rheumatic Diseases" - 6 trials